Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2000-08-23 to 2000-09-13
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2000
Report date:
2000

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
1996
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Version / remarks:
1996
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Version / remarks:
1998
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-{2-[(2-chloroacetyl)oxy]ethoxy}ethyl 2-chloroacetate
Cas Number:
106-78-5
Molecular formula:
C8H12O5Cl2
IUPAC Name:
2-{2-[(2-chloroacetyl)oxy]ethoxy}ethyl 2-chloroacetate
Test material form:
liquid

Test animals

Species:
rat
Strain:
Wistar
Remarks:
HsdCpb:WU / SPF-bred
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, District of Paderborn
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Age at study initiation: approx. 8 - 9 weeks
- Weight at study initiation: 190-234 g males, 160-71 g females
- Fasting period before study: approx. 17 hours ±2 hours
- Housing: polycarbonate cages; bedding low-dust wood granules type BK 8/15
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days before

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2.0°C
- Humidity (%): approx. 55 ± 5%
- Air changes (per hr): approx. 15-20 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours, illumination from 5 a.m. to 5 p.m.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: demineralized water with the aid of Cremophor EL 2% (v/v)
Details on oral exposure:
VEHICLE
- demineralized water with the aid of Cremophor EL 2% (v/v)

MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg body


Doses:
25, 200 and 2,000 mg/kg bw
No. of animals per sex per dose:
6 males and 9 females
Details on study design:
- Appearance and behavior were recorded several times on the day of treatment, and at least once a day thereafter. Where signs occurred, the type, period and intensity (1 = weak, 2 = moderate up to strong) were determined individually.
- During clinical observation all abnormal findings were registered and particular attention is paid to the following organ systems, localizations and physiological functions:
Appearance: fur, skin color, edemas, eyes, lacrimation, nasal discharge, salivation etc.
Behavior: grooming, vocalization, excitement, aggression, digging and preening movements, cannibalism etc.
Nervous system: reactivity, motility, reflexes, gait, paralysis, spasms, tremors etc.
Respiration: where assessable, e.g. frequency etc.
Cardiovascular system: where assessable, e.g. heart rate, pallor etc.
Posture: ventral, lateral recumbency etc.
Gastrointestinal functions: appearance of feces etc.
- Post-treatment Observation: The post-treatment observation period lasted for at least 14 days
- Body Weights: The body weights of the rats are recorded on day 1 before administration and then weekly. Additionally, all animals that died or are sacrificed are weighed.
- Necropsy: After the end of the post-treatment observation period the animals are anesthetized by inhaling diethyl ether and sacrificed. They are then subjected to a gross pathology examination, as are any animals which may have died intercurrently.

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 30 - < 50 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD50
Effect level:
> 50 - < 200 mg/kg bw
Based on:
test mat.
Mortality:
A dose of 25 mg/kg was tolerated by males and females without mortalities.
200 and 2,000 mg/kg were lethal for all females and 200 mg/kg for two males. The animals died on day 1 of the study.
Clinical signs:
other: A dose of 25 mg/kg was tolerated by males and females without clinical signs. At 200 mg/kg and above in both sexes the motility and the reactivity were decreased, gait uncoordinated, breathing labored, and the animals lay in abdominal position. Additional
Gross pathology:
In animals that died during the observation period dark-red discolored livers and slightly collapsed lungs were detected.
No gross pathologic changes were observed in animals sacrificed at the end of the study period

Any other information on results incl. tables

Table 1

Dose

(mg/kg b.w.)

Toxicological results*

Duration of signs

Time of death

Mortality

[%]

male

25

0

0

3

0

200

2

3

3

2h – 2d

5h

67

female

25

0

0

3

0

200

3

3

3

2h – 5h

3h – 5h

100

2000

3

3

3

10´ – 2h

40´ – 2h

100

* 1st column= number of dead animals; 2nd column = number of animals with signs; 3rd column= number of animals in the group

Applicant's summary and conclusion

Interpretation of results:
Category 2 based on GHS criteria
Conclusions:
L050 rat: >30 <50 mg/kg bw